Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.89 USD | -4.12% | +22.25% | -42.94% |
Business Summary
Number of employees: 6
Managers
Managers | Title | Age | Since |
---|---|---|---|
Lewis Bender
CEO | Chief Executive Officer | 65 | 11-12-31 |
Joseph Talamo
DFI | Director of Finance/CFO | 55 | Dec. 10 |
John Wesolowski
AUD | Comptroller/Controller/Auditor | 65 | 17-02-28 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Goldberg
BRD | Director/Board Member | 64 | 18-04-30 |
Lewis Bender
CEO | Chief Executive Officer | 65 | 11-12-31 |
Emer Leahy
BRD | Director/Board Member | 58 | 16-05-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 13,711,877 | 8,347,171 ( 60.88 %) | 0 | 60.88 % |
Company contact information
Intensity Therapeutics, Inc.
1 Enterprise Drive Suite 430
06880, Shelton
+
http://www.intensitytherapeutics.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-42.94% | 67.04M | |
+33.63% | 50.93B | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B |
- Stock Market
- Equities
- INTS Stock
- Company Intensity Therapeutics, Inc.